Affiliated with Eli Lilly and Company, a global pharmaceutical company, Lilly Asia Ventures provides capital, industry expertise, and global resources to promising life science companies with innovative technology and strong management teams. While their initial focus is on opportunities in China, they also consider investments in other parts of East and South Asia. The fund targets sectors such as pharmaceuticals, biotechnology, life sciences, and oncology.